Reproductive screening for fragile X syndrome, spinal muscular atrophy and cystic fibrosis to be added to MBS
28 March, 2022

Following an application by the Royal College of Pathologists of Australasia (RCPA) to the Medical Services Advisory Committee (MSAC), reproductive carrier screening for fragile X syndrome (FXS), spinal muscular atrophy (SMA) and cystic fibrosis (CF) will be listed on the Medicare Benefits Schedule (MBS). The funding forms part of the 2022/23 Federal Budget which is being announced this week.

Go Back

Page last updated:

Copyright © 2022 RCPA. All rights reserved.

30-Mar-2022
Top